RAIN-32 for Bile Duct Cancer

"Our team at Power assigned RAIN-32 a score of 2 for safety on our scale, as the Phase 2 trial offers some assurance in its safety but does not yet have any data to back efficacy."

"This study is now looking for participants at 10 distinct medical sites, which are located in Saint Louis, Houston and Boston plus 7 other cities. To reduce the amount of travel you need to undertake if accepted into this trial, it would be prudent to opt for a site located close to you."

"The first research on RAIN-32 was conducted in 2021 and sponsored by Rain Therapeutics Inc. After the completion of this initial study, which included 160 participants, it successfully gained Phase 3 drug approval. At present there are two ongoing trials for RAIN-32 being held across 32 cities and 15 countries worldwide."

"In 2021, the first RAIN-32 experiment was conducted at Leon Berard Center. Across 4 different trials to date, two of which are still in progress with a focus on Saint Louis, Missouri."

"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was originally published on November 1st 2021, is actively searching for volunteers. 65 participants are needed from 10 medical sites to complete the research objectives of this project."

"Affirmative. Referring to the information hosted on clinicaltrials.gov, it is evident that this medical experiment commenced recruiting subjects from November 1st 2021 and was recently updated in November 9th 2022 with a requirement for 65 participants across 10 sites."